Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (Investigational New Drugs, (2022), 40, 2, (290-299), 10.1007/s10637-021-01188-1)

Kyaw Z. Thein; Daniel D. Karp; Apostolia Tsimberidou; Jing Gong; Selma Sulovic; Jatin Shah; Denái R. Milton; David S. Hong; Filip Janku; Lacey McQuinn; Bettzy A. Stephen; Rivka Colen; Brett W. Carter; Timothy A. Yap; Sarina A. Piha-Paul; Siqing Fu; Funda Meric-Bernstam; Aung Naing

doi:10.1007/s10637-021-01194-3

Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (Investigational New Drugs, (2022), 40, 2, (290-299), 10.1007/s10637-021-01188-1)

Kyaw Z. Thein, Daniel D. Karp, Apostolia Tsimberidou, Jing Gong, Selma Sulovic, Jatin Shah, Denái R. Milton, David S. Hong, Filip Janku, Lacey McQuinn, Bettzy A. Stephen, Rivka Colen, Brett W. Carter, Timothy A. Yap, Sarina A. Piha-Paul, Siqing Fu, Funda Meric-Bernstam, Aung Naing

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The article Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study was originally published electronically on the publisher’s internet portal on 25 September 2021 without open access. The author decided to opt for Open Choice and to make the article an Open Access publication.

Original language	English (US)
Pages (from-to)	463
Number of pages	1
Journal	Investigational New Drugs
Volume	40
Issue number	2
DOIs	https://doi.org/10.1007/s10637-021-01194-3
State	Published - Apr 2022

ASJC Scopus subject areas

Oncology
Pharmacology
Pharmacology (medical)

MD Anderson CCSG core facilities

Clinical and Translational Research Center

Access to Document

10.1007/s10637-021-01194-3

Fingerprint

Dive into the research topics of 'Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (Investigational New Drugs, (2022), 40, 2, (290-299), 10.1007/s10637-021-01188-1)'. Together they form a unique fingerprint.

Cite this

Thein, K. Z., Karp, D. D., Tsimberidou, A., Gong, J., Sulovic, S., Shah, J., Milton, D. R., Hong, D. S., Janku, F., McQuinn, L., Stephen, B. A., Colen, R., Carter, B. W., Yap, T. A., Piha-Paul, S. A., Fu, S., Meric-Bernstam, F., & Naing, A. (2022). Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (Investigational New Drugs, (2022), 40, 2, (290-299), 10.1007/s10637-021-01188-1). Investigational New Drugs, 40(2), 463. https://doi.org/10.1007/s10637-021-01194-3

Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (Investigational New Drugs, (2022), 40, 2, (290-299), 10.1007/s10637-021-01188-1). / Thein, Kyaw Z.; Karp, Daniel D.; Tsimberidou, Apostolia et al.
In: Investigational New Drugs, Vol. 40, No. 2, 04.2022, p. 463.

Research output: Contribution to journal › Comment/debate › peer-review

Thein, KZ, Karp, DD, Tsimberidou, A, Gong, J, Sulovic, S, Shah, J, Milton, DR , Hong, DS, Janku, F, McQuinn, L, Stephen, BA, Colen, R, Carter, BW , Yap, TA , Piha-Paul, SA , Fu, S , Meric-Bernstam, F & Naing, A 2022, 'Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (Investigational New Drugs, (2022), 40, 2, (290-299), 10.1007/s10637-021-01188-1)', Investigational New Drugs, vol. 40, no. 2, pp. 463. https://doi.org/10.1007/s10637-021-01194-3

Thein KZ, Karp DD, Tsimberidou A, Gong J, Sulovic S, Shah J et al. Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (Investigational New Drugs, (2022), 40, 2, (290-299), 10.1007/s10637-021-01188-1). Investigational New Drugs. 2022 Apr;40(2):463. doi: 10.1007/s10637-021-01194-3

Thein, Kyaw Z. ; Karp, Daniel D. ; Tsimberidou, Apostolia et al. / Correction to : Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (Investigational New Drugs, (2022), 40, 2, (290-299), 10.1007/s10637-021-01188-1). In: Investigational New Drugs. 2022 ; Vol. 40, No. 2. pp. 463.

@article{9c1fb5f621d447cabdcaee4c5365bd2e,

title = "Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (Investigational New Drugs, (2022), 40, 2, (290-299), 10.1007/s10637-021-01188-1)",

abstract = "The article Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study was originally published electronically on the publisher{\textquoteright}s internet portal on 25 September 2021 without open access. The author decided to opt for Open Choice and to make the article an Open Access publication.",

author = "Thein, {Kyaw Z.} and Karp, {Daniel D.} and Apostolia Tsimberidou and Jing Gong and Selma Sulovic and Jatin Shah and Milton, {Den{\'a}i R.} and Hong, {David S.} and Filip Janku and Lacey McQuinn and Stephen, {Bettzy A.} and Rivka Colen and Carter, {Brett W.} and Yap, {Timothy A.} and Piha-Paul, {Sarina A.} and Siqing Fu and Funda Meric-Bernstam and Aung Naing",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2021.",

year = "2022",

month = apr,

doi = "10.1007/s10637-021-01194-3",

language = "English (US)",

volume = "40",

pages = "463",

journal = "Investigational New Drugs",

issn = "0167-6997",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - Correction to

T2 - Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (Investigational New Drugs, (2022), 40, 2, (290-299), 10.1007/s10637-021-01188-1)

AU - Thein, Kyaw Z.

AU - Karp, Daniel D.

AU - Tsimberidou, Apostolia

AU - Gong, Jing

AU - Sulovic, Selma

AU - Shah, Jatin

AU - Milton, Denái R.

AU - Hong, David S.

AU - Janku, Filip

AU - McQuinn, Lacey

AU - Stephen, Bettzy A.

AU - Colen, Rivka

AU - Carter, Brett W.

AU - Yap, Timothy A.

AU - Piha-Paul, Sarina A.

AU - Fu, Siqing

AU - Meric-Bernstam, Funda

AU - Naing, Aung

PY - 2022/4

Y1 - 2022/4

N2 - The article Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study was originally published electronically on the publisher’s internet portal on 25 September 2021 without open access. The author decided to opt for Open Choice and to make the article an Open Access publication.

AB - The article Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study was originally published electronically on the publisher’s internet portal on 25 September 2021 without open access. The author decided to opt for Open Choice and to make the article an Open Access publication.

UR - http://www.scopus.com/inward/record.url?scp=85118527883&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118527883&partnerID=8YFLogxK

U2 - 10.1007/s10637-021-01194-3

DO - 10.1007/s10637-021-01194-3

M3 - Comment/debate

C2 - 34731355

AN - SCOPUS:85118527883

SN - 0167-6997

VL - 40

SP - 463

JO - Investigational New Drugs

JF - Investigational New Drugs

IS - 2

ER -

Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a single-center, multi-arm phase Ib study (Investigational New Drugs, (2022), 40, 2, (290-299), 10.1007/s10637-021-01188-1)

Abstract

ASJC Scopus subject areas

MD Anderson CCSG core facilities

Access to Document

Other files and links

Fingerprint

Cite this